DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Dolastatin 10 is an investigational drug.
There have been 7 clinical trials for Dolastatin 10. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 1999.
The most common disease conditions in clinical trials are Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, and Carcinoma, Renal Cell. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and Barbara Ann Karmanos Cancer Institute.
Recent Clinical Trials for Dolastatin 10
|Dolastatin 10 in Treating Patients With Advanced Kidney Cancer||National Cancer Institute (NCI)||Phase 2|
|Dolastatin 10 in Treating Patients With Advanced Kidney Cancer||Mayo Clinic||Phase 2|
|Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma||National Cancer Institute (NCI)||Phase 2|